A Phase I Clinical Study Study of the Safety, Tolerability, and Pharmacokinetics of HX-1171 in Healthy Male Subjects

Trial Profile

A Phase I Clinical Study Study of the Safety, Tolerability, and Pharmacokinetics of HX-1171 in Healthy Male Subjects

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs HX 1171 (Primary)
  • Indications Atherosclerosis; Colitis; Cutaneous lupus erythematosus; Liver disorders; Systemic lupus erythematosus
  • Focus Adverse reactions; Expanded access
  • Sponsors Biotoxtech Co
  • Most Recent Events

    • 27 Feb 2017 Last checked against ClinicalTrials.gov record (NCT01548391).
    • 15 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top